RxDoctor Payments Data

Wellie Adlaon

Internal Medicine · Tishomingo, OKNPI 1245326925

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 557 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations. Among internal medicine clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,093in general payments, 2019–2025

Across 557 payments — averaging $12.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$2K
  • AbbVie$1K
  • Johnson & Johnson$856
  • Lundbeck LLC$782
  • Teva Pharmaceuticals USA, Inc.$623
  • Vanda Pharmaceuticals Inc.$539
  • plus $2K from 12 others

What the payments were for

  • Food & beverage$7,093100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,093 in reported general payments places this provider in the 90th percentile of 840 internal medicine providers in Oklahoma.

See all internal medicine providers in Oklahoma →

Most prescribed under Part D

DrugClaimsCost to plans & patients
PerserisRisperidone19$54,060
OzempicSemaglutide18$17,513
JardianceEmpagliflozin13$8,905
EliquisApixaban12$7,586
TrintellixVortioxetine Hydrobromide14$6,762
Lurasidone Hcl19$3,458
Fluphenazine Hcl14$1,880
Aripiprazole48$1,328
Haloperidol26$1,149
Gabapentin81$917
Ziprasidone Hcl26$848
Ventolin HfaAlbuterol Sulfate14$830
Olanzapine45$795
Clozapine20$750
Benztropine Mesylate61$591

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Indivior Inc.Perseris$391$54,06019 claims
PfizerEliquis$15$7,58612 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$93$6,76214 claims
Lilly USA, LLCOlanzapine$56$79545 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 840 internal medicine providers in Oklahoma.

Other internal medicine in Tishomingo

See the full list for Oklahoma →

Where these figures come from

Is this you, or does something look wrong? →